Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis
Michael A. van Es(University Medical Center Utrecht), Roel A. Ophoff(University of California, Los Angeles), Hiroko Kishikawa(Harvard University), Albert C. Ludolph(German Center for Neurodegenerative Diseases), Anne‐Marie Wills(Harvard University), Philip Van Damme(Universitair Ziekenhuis Leuven), Pamela Keagle(University of Massachusetts Chan Medical School), Frank P. Diekstra(King's College London), Robin Lemmens(VIB-KU Leuven Center for Microbiology), Christine Klein(University of Lübeck), Robert H. Brown(University of Massachusetts Chan Medical School), Vincenzo Silani(University of Milan), Hylke M. Blauw(University Medical Center Utrecht), Bastiaan R. Bloem(Radboud University Nijmegen), Jacobus J. van Hilten(Leiden University Medical Center), Hans Scheffer(Radboud University Nijmegen), Rebecca D. Folkerth(Office of Chief Medical Examiner), Nicola Ticozzi(University of Milan), David M. Wu(Brigham and Women's Hospital), Dagmar Verbaan(Leiden University Medical Center), Helenius J. Schelhaas(Radboud University Nijmegen), Patrick Lowe(University of Massachusetts Chan Medical School), Stefan Waibel(Universität Ulm), Wenhao Yu(National Cheng Kung University Hospital), Anneke J. van der Kooi(Amsterdam UMC Location University of Amsterdam), Ewout J. N. Groen(Utrecht University), Guo‐fu Hu(Northeast Agricultural University), Stefano Goldwurm(Istituto Ortopedico Gaetano Pini), Peter Heutink(Parkinson's Foundation), Eric A. M. Hennekam(University Medical Center Utrecht), Katsumi Fumoto(University Medical Center Utrecht), Gianni Pezzoli(Istituto Ortopedico Gaetano Pini), Thomas Gasser(Hertie Institute for Clinical Brain Research), Claudia Schulte(School of the Art Institute of Chicago), Edwin Cuppen(University Medical Center Utrecht), Wouter van Rheenen(King's College London), Marka van Blitterswijk(Mayo Clinic in Florida), Rubén Fernández‐Santiago(Hospital Clínic de Barcelona), Bart F.L. van Nuenen(Radboud University Nijmegen), Peter M. Andersen(Umeå University), Markus Weber(Kantonsspital St. Gallen), Wim Robberecht(KU Leuven), Anna Birve(Umeå University), Claudio Mariani(Istituto Ortopedico Gaetano Pini), Marianne de Visser(Amsterdam UMC Location University of Amsterdam), Ashley LeClerc(University of Massachusetts Chan Medical School), Caroline Dahlberg(Umeå University), Max Koppers(Cognitive Research (United States)), Paul W.J. van Vught(University Medical Center Utrecht), Daniela Berg(Christian-Albrechts-Universität zu Kiel)
Cited by 203
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
An atlas of active enhancers across human cell types and tissues
|Nature|2014|2.8k
Organoid Models of Human and Mouse Ductal Pancreatic Cancer
|Cell|2014|2.2k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k